Related Experiment Video
Updated: Jul 11, 2026
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Neuroprotective effect of geranylgeranylacetone against ischemia-induced retinal injury
Chikako Harada1, Kazuaki Nakamura, Xiaoli Guo
1Department of Molecular Neurobiology, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo, Japan.
Purpose:
This study was conducted to assess the effects of geranylgeranylacetone (GGA) on ischemia-induced retinal injury.
Methods:
Adult C57BL/6J mice were given oral treatments of GGA at 200 mg/kg daily for seven days. Ischemic retinal injury was carried out, and the extent of retinal cell death was quantitatively examined after 7 days. Immunohistochemistry for single-stranded DNA, phosphorylated form of p38 mitogen-activated protein kinase (p38 MAPK), and cleaved caspase-3 were performed one day after ischemic injury.
Results:
In GGA-treated mice, we found the number of surviving retinal neurons was significantly increased compared with vehicle-treated mice. Ischemia-induced phosphorylation of p38 MAPK, which mediates apoptosis of retinal ganglion cells, was suppressed by GGA treatment. In such retinas, cleaved caspase-3- and single-stranded DNA-positive cells were also decreased compared with vehicle-treated mice.
Conclusions:
Oral GGA is a useful treatment for various retinal degenerative diseases that involve ischemic injury.
